• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体催乳素细胞瘤。1例伴有颅内外转移的病例的临床病理、免疫组织化学及超微结构研究

Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.

作者信息

Scheithauer B W, Randall R V, Laws E R, Kovacs K T, Horvath E, Whitaker M D

出版信息

Cancer. 1985 Feb 1;55(3):598-604. doi: 10.1002/1097-0142(19850201)55:3<598::aid-cncr2820550320>3.0.co;2-s.

DOI:10.1002/1097-0142(19850201)55:3<598::aid-cncr2820550320>3.0.co;2-s
PMID:3965110
Abstract

A patient with a primary adenohypophyseal neoplasm who had a long course marked by multiple surgical resections, radiation therapy, and high-dose dopamine agonist therapy developed local invasion as well as cranial and extracranial osseous metastatic lesions. The serum prolactin levels were greatly elevated, and immunohistochemical studies demonstrated prolactin in the cytoplasm of primary and metastatic tumor cells. Ultrastructural features of lactotrophic differentiation, including misplaced granule exocytosis, were observed. This is the third reported case of prolactin cell carcinoma that metastasized despite high-dose dopamine agonist therapy. Analysis of the patient's serum prolactin showed no abnormality in the chromatographic profile of biologic activity.

摘要

一名患有原发性腺垂体肿瘤的患者病程漫长,经历了多次手术切除、放射治疗和高剂量多巴胺激动剂治疗,出现了局部侵袭以及颅骨和颅外骨转移病变。血清催乳素水平大幅升高,免疫组织化学研究显示原发性和转移性肿瘤细胞的细胞质中有催乳素。观察到了催乳素细胞分化的超微结构特征,包括错位的颗粒胞吐作用。这是第三例报告的催乳素细胞癌病例,尽管接受了高剂量多巴胺激动剂治疗仍发生了转移。对患者血清催乳素的分析显示其生物活性的色谱图谱无异常。

相似文献

1
Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.垂体催乳素细胞瘤。1例伴有颅内外转移的病例的临床病理、免疫组织化学及超微结构研究
Cancer. 1985 Feb 1;55(3):598-604. doi: 10.1002/1097-0142(19850201)55:3<598::aid-cncr2820550320>3.0.co;2-s.
2
Effect of bromocriptine and pergolide on pituitary tumor size and serum prolactin.溴隐亭和培高利特对垂体瘤大小及血清催乳素的影响。
AJNR Am J Neuroradiol. 1983 May-Jun;4(3):415-7.
3
Discordant responses of prolactinoma to two different dopamine agonists.泌乳素瘤对两种不同多巴胺激动剂的不一致反应。
Clin Endocrinol (Oxf). 1986 Apr;24(4):421-6. doi: 10.1111/j.1365-2265.1986.tb01647.x.
4
Reduction in size of prolactin-secreting tumours in men treated with pergolide.培高利特治疗的男性患者中泌乳素分泌性肿瘤体积缩小
Br Med J (Clin Res Ed). 1982 Aug 14;285(6340):465-7. doi: 10.1136/bmj.285.6340.465.
5
The effect of dopamine agonist therapy on large functionless pituitary tumours.多巴胺激动剂疗法对大型无功能垂体瘤的影响。
Clin Endocrinol (Oxf). 1985 May;22(5):679-86. doi: 10.1111/j.1365-2265.1985.tb03004.x.
6
Prolactin secreting pituitary carcinoma.分泌催乳素的垂体癌。
J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1205-6. doi: 10.1136/jnnp.55.12.1205.
7
Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography.长期治疗后停用多巴胺激动剂对催乳素瘤的影响。高清计算机断层扫描研究。
Lancet. 1984 Jul 28;2(8396):187-92. doi: 10.1016/s0140-6736(84)90480-x.
8
Prolactin reduction after combined therapy for prolactin macroadenomas.催乳素大腺瘤联合治疗后的催乳素降低
Neurosurgery. 1991 Apr;28(4):502-5. doi: 10.1097/00006123-199104000-00003.
9
Prolactin-secreting carcinoma of the pituitary: clinicopathological and immunohistochemical study of a case with intracranial and intraspinal dissemination.垂体泌乳素分泌型癌:1例伴颅内及椎管内播散病例的临床病理及免疫组化研究
Br J Neurosurg. 1997 Aug;11(4):350-5. doi: 10.1080/02688699746177.
10
Ultrastructural localization of prolactin in the human pituitary prolactinomas and its changes by bromocriptine treatment.
Acta Pathol Jpn. 1986 Aug;36(8):1123-30. doi: 10.1111/j.1440-1827.1986.tb02833.x.

引用本文的文献

1
Macroprolactinoma with secondary resistance to dopamine agonists: a case report and review of the literature.大催乳素腺瘤继发于多巴胺激动剂抵抗:病例报告及文献复习。
J Med Case Rep. 2023 Mar 17;17(1):96. doi: 10.1186/s13256-023-03820-5.
2
Malignancy course of pituitary adenoma in MEN1 syndrome: Clinical-Neuroradiological signs.MEN1综合征中垂体腺瘤的恶性病程:临床-神经放射学征象
Eur J Radiol Open. 2020 Jun 20;7:100242. doi: 10.1016/j.ejro.2020.100242. eCollection 2020.
3
Molecular pathology of sporadic pituitary tumors.散发性垂体瘤的分子病理学
Endocr Pathol. 1993 Dec;4(4):175-177. doi: 10.1007/BF02915459.
4
An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.1055 例连续垂体神经内分泌肿瘤 15 年队列中肿瘤进展为垂体癌的机构经验。
Endocr Pathol. 2019 Jun;30(2):118-127. doi: 10.1007/s12022-019-9568-5.
5
Beat the giant: case of a giant prolactinoma during pregnancy on cabergoline.战胜巨人:孕期使用卡麦角林治疗巨大泌乳素瘤的病例
Endocrinol Diabetes Metab Case Rep. 2018 Aug 23;2018. doi: 10.1530/EDM-18-0099. eCollection 2018.
6
Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).无功能性垂体腺瘤(垂体癌)的恶性转化。
Pituitary. 2018 Apr;21(2):217-229. doi: 10.1007/s11102-017-0857-z.
7
Pituitary carcinoma.垂体癌
Skull Base Surg. 1994;4(1):46-51. doi: 10.1055/s-2008-1058989.
8
Non-functioning pituitary carcinoma.无功能性垂体癌
Pituitary. 2004;7(3):149-156. doi: 10.1007/s11102-005-3411-3.
9
Proliferation Markers and EGF in ACTH-Secreting Adenomas and Carcinomas of the Pituitary.促肾上腺皮质激素分泌型垂体腺瘤和癌中的增殖标志物与表皮生长因子
Endocr Pathol. 1995 Spring;6(1):45-55. doi: 10.1007/BF02914988.
10
Pituitary Carcinomas.垂体癌
Endocr Pathol. 1996 Spring;7(1):21-35. doi: 10.1007/BF02739912.